Latest Mergers And Acquisitions News

Rincon Resources has validated historic assays revealing a broad, high-grade gold-copper corridor at its Telfer South Project and completed a $3.1 million capital raise to advance exploration.

D3 Energy has significantly expanded its South African helium footprint with new Exploration Rights and a Technical Cooperation Permit, while completing a well-supported A$6.12 million placement to fund upcoming drilling and development activities.

Sarytogan Graphite Limited has received $1.4 million from the European Bank for Reconstruction and Development, boosting funds for its Definitive Feasibility Study and advancing its strategic graphite project in Kazakhstan.

Metals X reported its fourth highest quarterly tin production at Renison with robust financials despite rising unit costs, while progressing the Rentails project and maintaining a strong cash position.

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

Leeuwin Metals continues to expand its Marda Gold Project resource with promising shallow gold intercepts at Evanston and Golden Orb, while assays for additional holes remain pending ahead of May drilling resumption.

Solis Minerals has expanded its lithium footprint with a fresh acquisition in Brazil, setting the stage for a busy drilling calendar across lithium and copper assets in South America.

TechGen Metals has reported a standout 20m @ 1.14% copper intercept at Mt Boggola and secured key drilling approvals at Blue Devil, setting the stage for multiple exploration campaigns in 2026.

Adveritas Limited surged to $15.08 million ARR, up 91% year-on-year, powered by a new self-serve SME platform and AI-driven product enhancements.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

hipages Group has acquired a majority stake in VIZ Insurance, marking its strategic entry into the insurance sector for tradies and broadening its platform offerings.